Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 302

1.

Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Oct 14;60(40):1382-4.

2.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

3.

Human papillomavirus vaccines: who will pay, who will receive, when to administer?

Saslow D, Wheeler CM.

Ethn Dis. 2007 Spring;17(2 Suppl 2):S2-8-13.

PMID:
17684807
4.

An overview on the implementation of HPV vaccination in Europe.

Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:128-35. Epub 2011 Jan 1. Review.

PMID:
21245659
5.

Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?

Saleem A, Tristram A, Fiander A, Hibbitts S.

Minerva Med. 2009 Dec;100(6):503-23. Review.

PMID:
20010484
6.

[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].

Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.

Med Klin (Munich). 2007 Jul 15;102(7):515-23. German.

PMID:
17634869
7.

Implementation of human papillomavirus immunization in the developing world.

Kane MA, Serrano B, de Sanjosé S, Wittet S.

Vaccine. 2012 Nov 20;30 Suppl 5:F192-200. doi: 10.1016/j.vaccine.2012.06.075. Review.

PMID:
23199963
8.

The epidemiology behind the HPV vaccine discovery.

Koutsky L.

Ann Epidemiol. 2009 Apr;19(4):239-44. doi: 10.1016/j.annepidem.2009.01.023. Review.

PMID:
19344861
9.

Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.

Ault K, Reisinger K.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S26-8. doi: 10.1016/S1201-9712(07)60018-6. Review.

10.

[Vaccines against human papillomavirus (HPV); between registration and implementation].

van Rossum TG, de Melker HE, Houweling H, Voordouw AC, Meijer CJ, Helmerhorst TJ, Kretzschmar M, Berkhof J, van der Noordaa J.

Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Review. Dutch.

PMID:
18549172
11.

Human papillomavirus vaccines: current status and future prospects.

Garland SM, Smith JS.

Drugs. 2010 Jun 18;70(9):1079-98. doi: 10.2165/10898580-000000000-00000. Review.

PMID:
20518577
12.

[What should be known for the introduction of an HPV vaccine?].

Muñoz N, Jacquard AC.

Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Review. French.

PMID:
18786806
13.

Public health issues related to HPV vaccination.

Hershey JH, Velez LF.

J Public Health Manag Pract. 2009 Sep-Oct;15(5):384-92. doi: 10.1097/PHH.0b013e3181a23de6. Review.

PMID:
19704306
14.

Human papillomavirus vaccines.

Satyaprakash A, Creed R, Ravanfar P, Mendoza N.

Dermatol Ther. 2009 Mar-Apr;22(2):150-7. doi: 10.1111/j.1529-8019.2009.01227.x. Review.

PMID:
19335726
15.

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool.

Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, Broutet N.

BMC Med. 2012 Nov 13;10:136. doi: 10.1186/1741-7015-10-136.

16.

Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.

Goldie SJ, O'Shea M, Diaz M, Kim SY.

Reprod Health Matters. 2008 Nov;16(32):86-96. doi: 10.1016/S0968-8080(08)32409-4.

PMID:
19027626
17.

Quadrivalent human papillomavirus vaccine.

Barr E, Tamms G.

Clin Infect Dis. 2007 Sep 1;45(5):609-7. Epub 2007 Jul 25. Review.

18.

Decreasing risk: impact of HPV vaccination on outcomes.

Hymel PA.

Am J Manag Care. 2006 Dec;12(17 Suppl):S473-83. Review.

20.

Recommendations for cervical cancer prevention in Latin America and the Caribbean.

Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX.

Vaccine. 2008 Aug 19;26 Suppl 11:L96-L107. doi: 10.1016/j.vaccine.2008.05.062. Review.

PMID:
18945407
Items per page

Supplemental Content

Write to the Help Desk